Cargando…
Impact of Urate Level on Cardiovascular Risk in Allopurinol Treated Patients. A Nested Case-Control Study
BACKGROUND: Gout gives rise to increased risk of cardiovascular events. Gout attacks can be effectively prevented with urate lowering drugs, and allopurinol potentially reduces cardiovascular risk. What target level of urate is required to reduce cardiovascular risk is not known. OBJECTIVES: To inve...
Autores principales: | Søltoft Larsen, Kasper, Pottegård, Anton, Lindegaard, Hanne M., Hallas, Jesper |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709004/ https://www.ncbi.nlm.nih.gov/pubmed/26751377 http://dx.doi.org/10.1371/journal.pone.0146172 |
Ejemplares similares
-
Is urate crystal precipitation a predictor of cardiovascular risk in hyperuricemic patients? A Danish cohort study
por: Larsen, Kasper Søltoft, et al.
Publicado: (2015) -
Impact of allopurinol use on urate concentration and cardiovascular outcome
por: Wei, Li, et al.
Publicado: (2011) -
Risk of Acute Myocardial Infarction Among New Users of Allopurinol According to Serum Urate Level: A Nested Case-Control Study
por: Rodríguez-Martín, Sara, et al.
Publicado: (2019) -
Presence of monosodium urate crystal deposition by dual-energy CT in patients with gout treated with allopurinol
por: Dalbeth, Nicola, et al.
Publicado: (2018) -
Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress
por: George, Jacob, et al.
Publicado: (2009)